Kolexia
Trensz Philippe
Oncologie médicale
Hôpital Hautepierre
Strasbourg, France
53 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Fatigue COVID-19 Atrophie Amyotrophie Néphrocarcinome Lymphomes Métastase tumorale Adénocarcinome

Industries

VIATRIS MEDICAL
2 collaboration(s)
Dernière en 2022
Janssen
2 collaboration(s)
Dernière en 2021
Ipsen
1 collaboration(s)
Dernière en 2021
Leo Pharma
1 collaboration(s)
Dernière en 2020

Dernières activités

PREVOIR: A Prospective, Randomized Trial Assessing the Feasibility of an Advance Care Planning Intervention for Patients Hospitalized in a French Cancer Center
Essai Clinique (Institut de cancérologie Strasbourg Europe)   12 mars 2024
ELAINEIII: An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Essai Clinique (Sermonix Pharmaceuticals Inc.)   07 mars 2024
Can health forums dedicated to breast cancer be useful to caregivers? Analysis of initial messages on the National League Against Cancer forum over a one-year period.
Gynecologie, obstetrique, fertilite & senologie   09 février 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients.
Journal of cachexia, sarcopenia and muscle   06 janvier 2024
Primary resistance to ALK inhibitors in -rearranged pleural metastatic lung adenocarcinoma: a case report.
Translational lung cancer research   28 novembre 2023
MegaMOST - A Multicenter, Open-label, Biology Driven, Phase II Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations /Characteristics in Advanced / Metastatic Tumors.
Essai Clinique (Centre Léon-Bérard)   16 novembre 2023
2054P Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer.
Cancer treatment and research communications   25 juin 2023
Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy.
European journal of applied physiology   20 mars 2023